Maia Biotechnology, INC. (MAIA) — 10-Q Filings

10-Q Filings (6)

• MAIA Biotech's Losses Widen Amid Soaring R&D, Going Concern Doubts Persist — Nov 7, 2025 Risk: high
  MAIA Biotechnology, Inc. reported a net loss of $8,903,189 for the three months ended September 30, 2025, a significant increase from the $2,735,987 net loss in
• MAIA Biotech Continues Pre-Revenue Phase, Focuses on THIO Clinical Trials — Aug 11, 2025 Risk: high
  MAIA Biotechnology, Inc. reported no revenue for the three and six months ended June 30, 2025, and June 30, 2024, consistent with its pre-commercialization stag
• MAIA Biotechnology Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  MAIA Biotechnology, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business activities, includi
• MAIA Biotechnology Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  MAIA Biotechnology, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial condition and results of operations, inc
• MAIA Biotechnology 10-Q: Financials and Offerings Detailed — Aug 9, 2024 Risk: medium
  MAIA Biotechnology, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on various financial activities including registered direct of
• MAIA Biotechnology Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  MAIA Biotechnology, Inc. (MAIA) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. MAIA Biotechnology, Inc. filed a 10-Q for the period ending March

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX